Ozempic face is a term describing the premature facial aging that occurs after rapid weight loss from GLP-1 medications like Ozempic (semaglutide), Wegovy, Mounjaro (tirzepatide), and Zepbound. When your body loses fat quickly, it also loses the structural fat compartments in your face that provide youthful volume and support. This leads to hollowed cheeks, sunken temples, deeper nasolabial folds, new jowling, and loose neck skin. The same phenomenon is sometimes called semaglutide face, Wegovy face, Mounjaro face, or tirzepatide face.

Yes. For mild cases, non-surgical treatments like Sculptra (which stimulates collagen) and hyaluronic acid fillers can restore some lost volume. For significant volume loss with skin laxity, a structural approach is needed. Dr. Ching’s Ascend Lift™ combines a deep plane facelift with SVF-enriched fat grafting to permanently reposition descended facial structures and restore volume using your own tissue. The right approach depends on how much weight you’ve lost, your age, your skin elasticity, and your goals.

For younger patients with excellent skin elasticity, some mild retraction may occur over 6–12 months if weight is partially regained. However, for patients over 40, the skin and structural changes are largely permanent. Collagen reserves decline with age, and once the facial fat compartments have been depleted and the skin has remodeled around the new volume, it does not “bounce back” on its own. Additionally, most patients don’t want to regain weight as a strategy for facial fullness.

Non-surgical treatments like fillers and Sculptra range from $2,000–$6,000+ per session and require repeat treatments every 6–12 months. The Ascend Lift™ is a one-time surgical procedure; pricing is discussed during your complimentary consultation because it depends on the extent of correction needed and whether additional procedures are combined. Many patients find that the one-time surgical investment is more cost-effective than years of filler maintenance. Financing options are available.

Yes. Most traditional facelifts tighten skin only, which can create a pulled or “windswept” appearance. The Ascend Lift™ is a deep plane technique that lifts the SMAS layer — the muscular foundation underneath the skin — allowing the entire midface, jawline, and neck to be repositioned as one unit. It also includes SVF stem cell–enriched fat grafting to rebuild the volume that GLP-1 weight loss removed. The combination of structural lift plus permanent volume restoration is what makes it particularly effective for Ozempic face.

You may be a good candidate if you’ve experienced noticeable facial volume loss or skin sagging after weight loss from Ozempic, Wegovy, Mounjaro, or any GLP-1 medication. Ideal surgical candidates have reached a stable weight for at least 3 months, are in good overall health, and have realistic expectations. Dr. Ching evaluates every patient individually during a free consultation to determine whether non-surgical maintenance, The Ascend Lift™, or a combination approach is the best path forward.

Most patients take 10–14 days off work. The first 3 days involve the most swelling and bruising. By week 2, most patients are presentable and can attend social events. Weeks 4–6 is when compliments typically begin as swelling fully resolves. Final results are visible around 3 months. For patients traveling to Honolulu, Dr. Ching’s team coordinates accommodations and post-operative care.

For surgical correction with The Ascend Lift™, Dr. Ching recommends waiting until your weight has been stable for at least 3 months to ensure optimal, lasting results. However, if you’re actively losing weight, there are proactive steps you can take now: establishing a facial baseline with standardized photos, maintaining high protein intake to support collagen, and starting non-surgical maintenance treatments like Sculptra or skin tightening at Asia Pacific Aesthetics’ MedSpa.

Energy-based devices like Morpheus8 and FaceTite, as well as PDO threads, can provide mild skin tightening. For patients with minor laxity after modest weight loss, these may be appropriate. However, for significant GLP-1 facial volume loss with structural descent, these devices tighten the skin without lifting the deeper SMAS layer or restoring lost volume. Many patients who pursue devices first ultimately require surgical correction to achieve their desired result. Dr. Ching offers all of these treatments and will recommend the most effective option for your specific situation.